At present, information on the serum levels of pituitary, gonadal, thyroid hormones, and endocrine disruptors in Nigerian women with ER-, PR-, HER-2-positive (+) and negative (−) breast cancers are sparse. The gene discussed is ESR1; the disease is breast carcinoma.